Klaus Kluck

1.4k total citations · 2 hit papers
16 papers, 715 citations indexed

About

Klaus Kluck is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Klaus Kluck has authored 16 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Klaus Kluck's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Klaus Kluck is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Klaus Kluck collaborates with scholars based in Germany, Switzerland and Singapore. Klaus Kluck's co-authors include Jan Budczies, Albrecht Stenzinger, Zhaohui Jin, Dan Sha, Frank A. Sinicrope, Daniel Kazdal, Susanne Beck, Peter Schirmacher, Michael Allgäuer and Michael Menzel and has published in prestigious journals such as Molecular Cancer, Nature Reviews Clinical Oncology and Cancer Discovery.

In The Last Decade

Klaus Kluck

12 papers receiving 708 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

2020 510 citations Dan Sha, Zhaohui Jin et al. Cancer Discovery profile →
Tumour mutational burden: clinical utility, challenges and emerging improvements

2024 47 citations Jan Budczies, Daniel Kazdal et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Klaus Kluck Germany	7	463	255	249	225	150	16	715
Yuzi Zhang China	14	568 1.2×	188 0.7×	187 0.8×	213 0.9×	176 1.2×	45	797
Soma Ghosh United States	8	455 1.0×	205 0.8×	234 0.9×	185 0.8×	87 0.6×	12	660
SL Moulder United States	8	620 1.3×	243 1.0×	354 1.4×	180 0.8×	202 1.3×	16	814
Leonie Voorwerk Netherlands	10	743 1.6×	298 1.2×	338 1.4×	238 1.1×	350 2.3×	17	1.0k
Marissa S. Mattar United States	12	313 0.7×	175 0.7×	230 0.9×	290 1.3×	153 1.0×	22	666
Meredith Pelster United States	9	556 1.2×	157 0.6×	149 0.6×	311 1.4×	190 1.3×	29	832
Opeyemi A. Jegede United States	12	329 0.7×	153 0.6×	341 1.4×	183 0.8×	96 0.6×	59	619
Yuezong Bai China	15	629 1.4×	268 1.1×	402 1.6×	248 1.1×	160 1.1×	60	987
Pieter‐Jan van Dam Belgium	16	335 0.7×	278 1.1×	209 0.8×	214 1.0×	89 0.6×	37	684
Marina Baretti United States	13	531 1.1×	333 1.3×	293 1.2×	367 1.6×	98 0.7×	50	969

Countries citing papers authored by Klaus Kluck

Since Specialization

Citations

This map shows the geographic impact of Klaus Kluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Kluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Kluck more than expected).

Fields of papers citing papers by Klaus Kluck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Kluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Kluck. The network helps show where Klaus Kluck may publish in the future.

Co-authorship network of co-authors of Klaus Kluck

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Kluck. A scholar is included among the top collaborators of Klaus Kluck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Kluck. Klaus Kluck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kluck, Klaus, Markus Ball, Paul Hofman, et al.. (2025). Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins. Journal of Thoracic Oncology. 21(2). 267–282.

Lutz, Manfred P., Rui Fang, Martina Kirchner, et al.. (2025). An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial. Molecular Cancer. 24(1). 202–202.

Menzel, Michael, Martina Kirchner, Klaus Kluck, et al.. (2024). Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors. The Journal of Pathology Clinical Research. 10(2). e354–e354. 2 indexed citations

Ball, Markus, Klaus Kluck, Michael Menzel, et al.. (2024). Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor. Journal of Molecular Diagnostics. 26(6). 479–486.

Ball, Markus, Martina Kirchner, Olaf Neumann, et al.. (2024). Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test. Journal of Molecular Diagnostics. 27(2). 154–162.

Budczies, Jan, Daniel Kazdal, Michael Menzel, et al.. (2024). Tumour mutational burden: clinical utility, challenges and emerging improvements. Nature Reviews Clinical Oncology. 21(10). 725–742. 47 indexed citations breakdown →

Kluck, Klaus, Michael Menzel, Susanne Beck, et al.. (2023). Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. Cell Death Discovery. 9(1). 126–126. 6 indexed citations

Kluck, Klaus, Markus Ball, Martina Kirchner, et al.. (2023). Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas. Lung Cancer. 180. 107212–107212. 5 indexed citations

Seker‐Cin, Huriye, Timothy Kwang Yong Tay, Daniel Kazdal, et al.. (2023). Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications. Lung Cancer. 184. 107317–107317. 3 indexed citations

10.

Menzel, Michael, Volker Endris, Constantin Schwab, et al.. (2023). Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD). Translational Oncology. 35. 101706–101706. 8 indexed citations

11.

Rempel, Eugen, Klaus Kluck, Susanne Beck, et al.. (2022). Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). npj Precision Oncology. 6(1). 36–36. 49 indexed citations

12.

Wrensch, Margaret, Peter G. J. ter Horst, Wilhelm Bloch, et al.. (2022). Influence of a 12-month supervised, intensive resistance, aerobic and impact exercise intervention on muscle strength in prostate cancer patients undergoing anti-hormone therapy: Study protocol for the randomized, controlled Burgdorf study. Contemporary Clinical Trials. 114. 106685–106685. 1 indexed citations

13.

Budczies, Jan, Klaus Kluck, Susanne Beck, et al.. (2022). Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types. The Journal of Pathology Clinical Research. 8(4). 371–382. 21 indexed citations

14.

Budczies, Jan, Martina Kirchner, Klaus Kluck, et al.. (2021). A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma. OncoImmunology. 10(1). 1860586–1860586. 43 indexed citations

15.

Sha, Dan, Zhaohui Jin, Jan Budczies, et al.. (2020). Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors. Cancer Discovery. 10(12). 1808–1825. 510 indexed citations breakdown →

16.

Budczies, Jan, Klaus Kluck, Wolfgang Walther, & Ulrike Stein. (2019). Decoding and targeting the molecular basis of MACC1-driven metastatic spread: Lessons from big data mining and clinical-experimental approaches. Seminars in Cancer Biology. 60. 365–379. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact